![David Hyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Dr. David Hyman, MD, is a Chief Medical Officer at Eli Lilly & Co. and a Chief Medical Officer at Loxo Oncology, Inc.
David Hyman active positions
| Companies | Position | Start |
|---|---|---|
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 16/10/2023 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
- Stock Market
- Insiders
- David Hyman
